Iambic Therapeutics IPO: Date, Status and What We Know
FiledUnited States · Nasdaq Global Select MarketIAM
IPO facts
- Status
- Filed
- Market
- United States
- Country
- United States
- Exchange
- Nasdaq Global Select Market
- Ticker
- IAM
- Sector
- Biotechnology (AI drug discovery)
- Filing date
- First trading day
- Not announced
- Price range
- Not announced
- Offering size
- Not announced
- Last valuation
- Not announced
About Iambic Therapeutics
Iambic Therapeutics is a San Diego-based clinical-stage company that combines AI with automated chemistry and biology experiments to discover and develop medicines.
IPO notes
Iambic Therapeutics publicly filed its Form S-1 on 21 September 2026. It has applied to list its common stock on the Nasdaq Global Select Market under IAM; the number of shares and the price range are blank in the filing (sec.gov). No pricing date had been announced as of 5 October 2026.
Other IPOs in this market
Sources
- sec.gov · Form S-1 registration statement ·
Named as plain text with what each source states and the date it was checked.